US 12089575
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
granted A61KA61K2039/505A61K49/0008
Quick answer
US patent 12089575 (Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K49/0008, A61P, A61P35/00